The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...